Low MIB-1 labeling index in anti-HCV positive hepatocellular carcinoma

被引:0
作者
Watanuki, A
Ohwada, S
Fukusato, T
Kawate, S
Makita, F
Morishita, Y
机构
[1] Gunma Univ, Sch Med, Dept Surg 2, Gunma 3718511, Japan
[2] Gunma Univ Hosp, Div Diagnost Pathol, Gunma, Japan
[3] Nishi Gunma Hosp, Natl Sanatorium, Gunma 3718511, Japan
关键词
hepatocellular carcinoma; anti-HCV antibody; proliferative activity; Ki-67; MIB-1; argyrophilic nucleolar organizer regions; p53; c-myc;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It has been reported that hepatitis C virus-related hepatocellular carcinoma (HCC) patients survive longer than hepatitis B virus-related patients. In this study, since HCC patients positive for anti-HCV antibody had significantly longer disease-free survival (p<0.05), we evaluated the proliferative activity of 58 resected HCCs and the status of their viral infections. Ki-67 (MIB-1) immunostaining, argyrophilic nucleolar organizer regions and c-myc gene amplification were examined as parameters of proliferation, and p53 overexpression was examined in relation to clinicopathologic features and prognosis. Thirty-nine patients with HCC (67%) were positive for anti-HCV antibody alone, five (9%) were negative for both anti-HCV and HBV antibodies, two (3%) were positive for both anti-HCV and HBV antibodies, and 12 (21%) had HBsAg alone. HCC patients with anti-HCV antibody had a lower MIB-1 labeling index (LI) than HCC patients negative for the antibody (p<0.05), irrespective of the serum HBsAg status. However, there was no significant correlation between anti-HCV antibody and other proliferative parameters. MIB-1 could simply be related to cellular proliferation. On the other hand, the other parameters may be related to tumor progression as well as proliferation. HCV-related HCC does have lower proliferative activity and a better prognosis.
引用
收藏
页码:1017 / 1022
页数:6
相关论文
共 50 条
  • [21] Characteristics of anti-HCV antibody-positive patients with hepatocellular carcinoma on chronic hemodialysis: Recommendation of periodic ultrasonography for early detection
    Sakai, Y
    Izumi, N
    Tazawa, J
    Uchihara, M
    Akiba, T
    Marumo, F
    Sato, C
    NEPHRON, 1996, 74 (02): : 386 - 389
  • [22] Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas
    Devaprasath, A
    Chacko, G
    NEUROLOGY INDIA, 2003, 51 (03) : 336 - 340
  • [23] Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression Clinical article
    Widhalm, Georg
    Wolfsberger, Stefan
    Preusser, Matthias
    Fischer, Ingeborg
    Woehrer, Adelheid
    Wunderer, Joerg
    Hainfellner, Johannes A.
    Knosp, Engelbert
    JOURNAL OF NEUROSURGERY, 2009, 111 (03) : 563 - 571
  • [24] Histopathology and MIB-1 labeling index predicted recurrence of meningiomas - A proposal of diagnostic criteria for patients with atypical meningioma
    Ho, DMT
    Hsu, CY
    Ting, LT
    Chiang, H
    CANCER, 2002, 94 (05) : 1538 - 1547
  • [25] Prognostic utility and characteristics of MIB-1 labeling index as a proliferative activity marker in childhood low-grade glioma: a retrospective observational study
    Gorodezki, David
    Zipfel, Julian
    Bevot, Andrea
    Naegele, Thomas
    Ebinger, Martin
    Schuhmann, Martin U.
    Schittenhelm, Jens
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (04)
  • [26] IMMUNOHISTOCHEMICAL DETECTION OF ABERRANT P53 EXPRESSION IN HEPATOCELLULAR-CARCINOMA - CORRELATION WITH CELL PROLIFERATIVE ACTIVITY INDEXES, INCLUDING MITOTIC INDEX AND MIB-1 IMMUNOSTAINING
    NAGAO, T
    KONDO, F
    SATO, T
    NAGATO, Y
    KONDO, Y
    HUMAN PATHOLOGY, 1995, 26 (03) : 326 - 333
  • [27] CORRELATION BETWEEN THE BROMODEOXYURIDINE LABELING INDEX AND THE MIB-1 AND KI-67 PROLIFERATING CELL INDEXES IN CEREBRAL GLIOMAS
    ONDA, K
    DAVIS, RL
    SHIBUYA, M
    WILSON, CB
    HOSHINO, T
    CANCER, 1994, 74 (07) : 1921 - 1926
  • [28] Preoperative Risk Stratification of Increased MIB-1 Labeling Index in Pituitary Adenoma: A Newly Proposed Prognostic Scoring System
    Maiseyeu, Ivan
    Gueresir, Agi
    Vatter, Hartmut
    Herrlinger, Ulrich
    Becker, Albert
    Wach, Johannes
    Gueresir, Erdem
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [29] BGX-Ki-67 Index as a Supplementary Marker to MIB-1 Index, Enabling More Precise Distinction Between Luminal A and B Subtypes of Breast Carcinoma and Eliminating the Problem of Membranous/Cytoplasmic MIB-1 Staining
    Niemiec, Joanna
    Adamczyk, Agnieszka
    Ambicka, Aleksandra
    Mucha-Malecka, Anna
    Wysocki, Wojciech M.
    Majchrzyk, Kaja
    Rys, Janusz
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (03) : 419 - 429
  • [30] ANTI-HCV ANTIBODY IN CHINESE CIRRHOTIC-PATIENTS WITH OR WITHOUT HEPATOCELLULAR-CARCINOMA - RELATION TO MULTITRANSFUSION
    CHANG, WY
    WANG, LY
    CHUANG, WL
    CHEN, SC
    LU, SN
    YOU, SL
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1992, 7 (02) : 128 - 131